Klin Onkol 1997; 10(3): 80-82.
The authors try to summarize the issue of anthracycline cardiotoxicity in children with acute lymphoblastic leukemia. They focus on possible risk factors of development of acute and late antracycline cardiotoxicity, on their clinical manifestations, possibilities of monitoring and prevention.
